Scientometrics
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jul 28, 2022; 28(28): 3720-3731
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3720
Table 1 Top 10 countries published Clostridium difficile-associated diarrhea between 2001 and 2020
Position
Country
No. of publication
%
1stUnited States358544.11
2ndUnited Kingdom101312.46
3rdCanada5566.84
4thGermany4345.34
5thFrance3834.71
6thChina3153.88
7thNetherlands2733.36
8thAustralia2613.21
9thItaly2443.00
10thSpain2382.93
Table 2 Ten most productive and influential institutions in Clostridium difficile-associated diarrhea between 2001 and 2020
Position
Institution
Country
No. of publication
%
1stUniversity of LeedsUnited Kingdom2032.50
2ndLeiden University Medical Center-LUMCNetherlands1912.35
3rdHarvard Medical SchoolUnited States1832.25
4thVA Medical CenterUnited States1732.13
5thLeeds Teaching Hospitals NHS TrustUnited Kingdom1601.97
6thBeth Israel Deaconess Medical CenterIsrael1351.66
7thWashington University School of Medicine in St. LouisUnited States1181.45
8thEdward Hines Jr. VA HospitalUnited States1151.42
9thThe University of Western AustraliaAustralia1091.34
10thBaylor College of MedicineUnited States1081.33
Table 3 Top 10 related funding agencies in Clostridium difficile-associated diarrhea between 2001 and 2020
Position
Funding agencies
Country
No. of publication
%
1stNational Institutes of HealthUnited States88410.88
2ndU.S. Department of Health and Human ServicesUnited States84110.35
3rdNational Institute of Allergy and Infectious DiseasesUnited States5396.63
4thNational Institute of Diabetes and Digestive and Kidney DiseasesUnited States2392.94
5thMerckUnited States1712.10
6thNational Center for Advancing Translational SciencesUnited States1541.89
7thMedical Research CouncilUnited Kingdom1501.85
8thNational Institute of General Medical SciencesUnited States1461.80
9thPfizerUnited States1371.69
10thUnited Kingdom Research and InnovationUnited Kingdom1321.62
Table 4 Ten most productive and influential journals in Clostridium difficile-associated diarrhea between 2001 and 2020
Position
Journal
n
%
IF1
1stInfection Control and Hospital Epidemiology3043.743.254
2ndAnaerobe2763.43.331
3rdClinical Infectious Diseases2513.099.097
4thJournal of Hospital Infection2122.613.926
5thJournal of Clinical Microbiology1832.255.948
6thPlos One1812.233.240
7thAmerican Journal of Infection Control1692.082.918
8thAntimicrobial Agents and Chemotherapy1301.65.191
9thJournal of Antimicrobial Chemotherapy1241.535.790
10thClinical Microbiology and Infection1171.448.067
1Impact factor (IF) based on Journal Citation Reports (JCR) 2020 from Clarivate Analytics.
Table 5 Ten most cited publications and authors between 2001 and 2020 in in Clostridium difficile-associated diarrhea
Ref.
Title
Year
Source title
Cited by
Citation index
Impact index per article1
Cohen et al[35]“Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)”2010Infection Control and Hospital Epidemiology2370237.0313.9
van Nood et al[42]“Duodenal infusion of donor feces for recurrent clostridium difficile”2013New England Journal of Medicine2140305.7241.3
Loo et al[37]“A predominantly clonal multi-institutional outbreak of Clostridium difficile - Associated diarrhea with high morbidity and mortality”2005New England Journal of Medicine1601106.788.6
Lessa et al[44]“Burden of Clostridium difficile infection in the United States”2015New England Journal of Medicine1430286.0234.3
Surawicz et al[41]“Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections”2013American Journal of Gastroenterology1087155.3116.8
Louie et al[38]“Fidaxomicin versus vancomycin for Clostridium difficile infection”2011New England Journal of Medicine1074119.391.4
Kelly and LaMont[36]“Clostridium difficile - More difficult than ever”2008New England Journal of Medicine101984.968.1
Rupnik et al[40]“Clostridium difficile infection: New developments in epidemiology and pathogenesis”2009Nature Reviews Microbiology98589.573.4
Zar et al[43]“A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity”2007Clinical Infectious Diseases93571.958.9
Pépin et al[39]“Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity”2004CMAJ91657.345.6
1The impact index per article is presented based on Reference Citation Analysis [Source: Baishideng Publishing Group Inc. (Pleasanton, CA 94566, United States)].